SGL Investment Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
SGL Investment Advisors's LLY Position: Q1 2026 in Review
SGL Investment Advisors increased its Eli Lilly (LLY) stake by 1.8% in Q1 2026, buying an estimated $14.2K and bringing the position to 798 shares worth $772K. The position accounts for 0.29% of the portfolio, ranked #69.
SGL Investment Advisors first reported a position in LLY in Q3 2024 and has held it in 7 quarters since. The position peaked at $800K in Q4 2025. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- SGL Investment Advisors held 798 shares of Eli Lilly worth $772K as of Q1 2026.
- SGL Investment Advisors bought 14 Eli Lilly shares in Q1 2026, an estimated $14.2K.
- Eli Lilly made up 0.29% of SGL Investment Advisors's portfolio in Q1 2026, its #69 holding.
- SGL Investment Advisors first reported a position in Eli Lilly in Q3 2024 and has held it in 7 quarters since.
- SGL Investment Advisors's Eli Lilly position peaked at $800K in Q4 2025.
- 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on SGL Investment Advisors's 13F filing for Q1 2026, filed 12 May 2026.